Automated Cell Counters Market Size, Share Report, Analysis, Trends, Growth, 2030

Automated Cell Counters Industry Prospective:

The global automated cell counters market size was evaluated at $9.1 billion in 2022 and is slated to hit $13.2 billion by the end of 2030 with a CAGR of nearly 7.75% between 2023 and 2030.

Request Free Sample

Automated Cell Counters Market: Overview

Automated cell counters are electronic devices that count the cells in plants, animals, human beings, viruses, and bacteria along with the cells of other origins. Furthermore, the cell counting process commences with the loading of a section into an automated cell counter, which is then passed over a narrow tube. Moreover, these products find a slew of applications in lab tests for counting cells.

Key Insights

• As per the analysis shared by our research analyst, the global automated cell counters market is projected to expand annually at the annual growth rate of around 7.75% over the forecast timespan (2023-2030)
• In terms of revenue, the global automated cell counters market size was evaluated at nearly $9.1 billion in 2022 and is expected to reach $13.2 billion by 2030.
• The global automated cell counters market is anticipated to grow rapidly over the forecast timeline owing to a prominent surge in the cases of diseases such as cancer, HIV, diphtheria, measles, and other kinds of blood disorders.
• In terms of product type, the fluorescence image-based cell counter segment is slated to register the highest CAGR over the analysis period.
• Based on application, the blood cells segment is expected to dominate the segmental growth over the assessment timeline.
• Region-wise, the North American automated cell counters industry is projected to register the fastest CAGR during the assessment timeline.

Automated Cell Counters Market: Growth Factors

Rise in the incidences of chronic diseases globally will steer the global market expansion by 2030

A prominent surge in the cases of diseases such as cancer, HIV, diphtheria, measles, and other kinds of blood disorders will drive the global automated cell counters market trends. A surge in the need for counting cells for diagnosis and treatment of chronic illness will further embellish the expansion of the global market. As per the report of WHO published in November 2021, nearly 38 million got infected with HIV by 2020. Moreover, in 2020, about 7, 00,000 individuals died due to HIV. Furthermore, a rise in scientific and technological breakthroughs will favorably leverage the expansion of the market across the globe. Supportive government policies and huge fund allocations in research activities pertaining to the

development of new automated cell counters will spearhead the market space in the coming years. New product launches have favorably impacted the expansion of each market and are likely to do so even in the foreseeable future. For instance, in August 2022, DeNovix Inc., a key manufacturer of CellDrop Automated Cell Counter, launched two nuclei counting applications of varied isolated nuclei & intact cells. Additionally, in April 2021, CytoSMART Technologies, a Holland-based firm manufacturing smart devices, launched a fluorescence cell counter referred to as CytoSMART Exact FL, an automated and dual fluorescence cell counter that can provide unrivaled performance and extended view of the field. Such strategic initiatives will impel the scope of the growth of the global market.

Automated Cell Counters Market: Restraints

High product costs can impede global industry expansion over the next eight years

Huge costs and lack of availability of skilled professionals can hinder the growth of the global automated cell counters industry. Furthermore, poor healthcare facilities in emerging economies are anticipated to halt the expansion of the global industry.

Automated Cell Counters Market: Opportunities

Large-scale consumption of alcoholic beverages will open new growth avenues for the global market

Increase in intake of alcohol and cigar smoking and an unhealthy & haphazard lifestyle along with changing food habits has paved the way for the mammoth growth of the automated cell counters market across the globe.

Automated Cell Counters Market: Challenges

Stringent government regulations will restrict global industry expansion over the forecast period

Strict government laws mandating approval of using the product as well as licensing of the product can pose a big threat to the expansion of the global automated cell counters industry.

Automated Cell Counters Market: Segmentation

The global automated cell counters market is sectored into product type, application, and region.        

In terms of product type, the global automated cell counters market is segregated into fluorescence image-based cell counter, coulter counter, and flow cytometers segments. Furthermore, the fluorescence image-based cell counter segment, which gathered nearly a fourth-fifth of the global market revenue share in 2022, is projected to register the fastest CAGR in the next couple of years. The growth of the segment in the forecasting timespan can be owing to an increase in the number of individuals affected due to urinary tract infections, diabetes, and kidney disorders.

Based on the application, the global automated cell counters industry is sectored into cell lines, blood cells, and microbial segments. Furthermore, the blood cells segment, which garnered a huge chunk of the global industry share in 2022, is forecast to dominate the global industry over the analysis timespan. The segmental expansion over the assessment timespan can be subject to a rise in blood cell diseases such as thalassemia and cancer.

Automated Cell Counters Market: Report Scope

 Automated Cell Counters Market: Regional Insights

Asia-Pacific is set to retain dominant position in the global automated cell counters market over 2023-2030

Asia-Pacific, which contributed about two-fifths of the global automated cell counters market revenue in 2022, will be a leading region over the projected timeframe. Furthermore, the regional market growth can be subject to a rise in the presence of giant firms in the countries. Apart from this, the huge demand for toxicology testing equipment and personalized medicine in countries such as Japan and China will proliferate the regional market size. Additionally, rise in the chronic disorders in the emerging economies of Asia will further steer the regional market trends.

North American automated cell counters industry is set to register the fastest CAGR in the ensuing years owing to the rise in the manufacture of medical devices as well as its use in hospitals and clinics in countries such as Canada and the U.S. In addition to this, breakthroughs in the healthcare sector will further promulgate the scope of growth of the industry in the region. Supportive government schemes pertaining to the use of medical devices along with approvals from healthcare authorities such as the U.S. FDA over medical device applications in the healthcare sector will prompt regional industry growth.

 Automated Cell Counters Market: Competitive Space

The global automated cell counters market profiles key players such as:

• Thermo Fischer Scientific
• Abbott Laboratories
• Countstar Inc.
• Bio-Rad Laboratories Inc.
• Agilent Technologies Inc.
• Beckman Coulter Inc. (Danaher)
• F. Hoffmann-La Roche Ltd
• Chemometec A/S
• ALIGNEDGENETICS
• Nanoentek
• Olympus Corporation
• MERCK KGaA
• Sysmex Corporation
• Nexcelom Bioscience LLC.

The global automated cell counters market is segmented as follows:

By Application

• Cell Lines
• Blood Cells
• Microbial Cells

By Product Type

• Fluorescence Image-based Cell Counter
• Coulter Counter
• Flow Cytometers

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa